(Q74776183)

English

Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study

scientific article published on 01 June 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

based on heuristic

inferred from title

author name string

Elis A

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Bental T

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Kimchi O

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Ravid M

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Lishner M

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

63

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

682-685

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Dobutamine: development of a new catecholamine to selectively increase cardiac contractility

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Effect of dobutamine on pulmonary gas exchange in patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Effects of short-term administration of dobutamine on left ventricular performance, exercise capacity, norepinephrine levels, and lymphocyte adrenergic receptor density in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Long-term benefit of dobutamine in patients with congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Drug-induced conditioning in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Inotropic therapy of the failing myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Medical advances in the treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Arterial hemodynamics and cardiac effects of enoximone, dobutamine, and their combination in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Sudden death and staged therapy for hemodynamic stabilization in patients enrolled in a heart transplantation program

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Intermittent dobutamine infusion in severe chronic heart failure in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Future approaches to pharmacologic therapy for congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0009-9236(98)90092-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74776183&oldid=1899967624"